Foghorn Therapeutics Inc.
SEC CIK 1822462 · FHTX · last insider filing 2026-06-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Parshall B Lynne | Director | filed 2022 - 2026 |
| Gill Simba | Director | filed 2020 - 2026 |
| Smith IAN F | Director | filed 2021 - 2026 |
| Lynch Thomas J. Jr. | Director | filed 2022 - 2026 |
| Cole Douglas G. | Director | filed 2020 - 2026 |
| Biller Scott | Director | filed 2020 - 2026 |
| Mendelsohn Michael | Director | filed 2020 - 2026 |
| Duty Stuart | Director | filed 2025 - 2026 |
| Gallagher Neil | Director | filed 2025 - 2026 |
| Gottschalk Adrian | Director · See Remarks | filed 2020 - 2026 |
| Afeyan Noubar | Director | filed 2020 - 2026 |
| Flagship Ventures Management, Inc. | Director | filed 2020 - 2026 |
| Flagship Ventures Fund V, L.P. | Director | filed 2020 - 2026 |
| Flagship Ventures Opportunities Fund I, L.P. | Director | filed 2020 - 2026 |
| Flagship Ventures Fund V General Partner LLC | Director | filed 2020 - 2026 |
| Flagship Ventures Opportunities Fund I General Partner LLC | Director | filed 2020 - 2026 |
| Flagship Pioneering Special Opportunities Fund II, L.P. | Director | filed 2020 - 2026 |
| Flagship Pioneering Fund VII, L.P. | Director | filed 2024 - 2026 |
| Flagship Pioneering Fund VII General Partner LLC | Director | filed 2024 - 2026 |
| Flagship Pioneering Special Opportunities Fund II General Partner LLC | Director | filed 2020 - 2026 |
| Koppel Adam | Director | filed 2020 - 2024 |
| Kadoch Cigall | Director | filed 2020 - 2022 |
| Baselga Jose | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Maynard Ryan D | Chief Financial Officer | filed 2026 - 2026 |
| Cardama Alfonso Quintas | Chief Medical Officer | filed 2023 - 2026 |
| Bellon Steven F. | See Remarks | filed 2020 - 2026 |
| Lacascia Michael | Chief Legal Officer | filed 2020 - 2026 |
| Costa Carlos | Chief People Officer | filed 2022 - 2026 |
| Rivkin Anna | Chief Business Officer | filed 2024 - 2026 |
| Humer Kristian | Chief Financial Officer | filed 2024 - 2025 |
| Cavalie Fanny | Chief Strategy/Bus Ops Officer | filed 2022 - 2024 |
| Reine Allan | Chief Financial Officer | filed 2020 - 2024 |
| Agresta Samuel | Chief Medical Officer | filed 2020 - 2023 |
| Decicco Carl | Chief Scientific Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.